2014/11/14 10:42


AsiaNet 58594(1260)





▽Biosafe Groupについて

1997年に創業したBiosafe Groupは自動細胞プロセッシングシステムの設計、製造、マーケティングを活発に行っている。スイスに本社を置く株式非公開企業であるBiosafe Groupは地域別の子会社(ジュネーブ、ヒューストン、香港、上海、サンパウロ)を通じて事業を行っているほか、50カ国以上で直接ないし代理店を通じて営業活動をしている。


Christopher Bolton


Biosafe Group SA


ソース:Biosafe Group S.A.

Biosafe Inaugurates Its Expanded China Business


EYSINS, Switzerland, Nov. 14 /PRN=KYODO JBN/ --

    Following the full registration of its product range by the Chinese FDA

last April, Biosafe is gearing up its activities in the People's Republic of

China with a major expansion of its Shanghai-based operations, including

staffing and facilities consolidation. Such expansion will enable Biosafe to

support the many new developments in China within the Cord Blood Banking,

Regenerative Medicine and Bioprocessing markets where the Group holds


    (Logo: )

    To mark this significant business extension, Biosafe is today holding an

official celebration event at the Grand Hyatt Hotel Shanghai, with a conference

on stem cell therapy that will include a keynote presentation from Dr. Joanne

Kurtzberg (Director, Pediatric Blood and Marrow Transplant Program, Duke

University, USA).

    Olivier Waridel, CEO of the Biosafe Group commented: "This expansion of our

China operations underlines the commitment of Biosafe to cooperate with the

Chinese cell therapy community, by working more closely with our clients and

scientific partners in the People's Republic of China. Biosafe looks forward to

further developing close relationships with them and is enthusiastic about

jointly supporting their efforts".

    About the Biosafe Group

    Founded in 1997 the Biosafe Group is active in the design, manufacture and

marketing of automated cell processing systems. Headquartered in Switzerland

and privately-owned, the Biosafe Group operates through regional subsidiaries

(Geneva, Houston, Hong-Kong, Shanghai and Sao Paulo) and is present in more

than 50 countries, either directly or through distributors.


    For further information:

    Christopher Bolton


    Biosafe Group SA


    SOURCE: Biosafe Group